Related Experiment Video
Updated: Aug 11, 2026

Cancer-Associated Fibroblasts from Mouse Mammary Tumors as Tools for Molecular and Computational Studies
Published on: July 3, 2025
Activation of STAT3/5 signal pathways in complete mole and repression in choriocarcinoma cell lines
Hidenori Kato1, Takafumi Inoue, Kazuo Asanoma
1Division of Molecular and Cell Therapeutics, Department of Molecular Genetics, Medical Institute of Bioregulation, Kyushu University, Tsurumihara 4546, Beppu City, Oita 874-0838, Japan. hidekato@beppu.kyushu-u.ac.jp
Objective:
Because our previous study of microarray suggested that STAT5 and its downstream target, survivin, were up-regulated in complete mole (CM), we clarified the status of STAT-mediated signal transduction in CM and choriocarcinoma (CC).
Study Design:
Proteins from 4 CM and normal villi and from 3 CC cell lines were subjected to Western blot (WB) analysis to evaluate STAT3 and 5 activation. After STAT and MEK inhibitor were added to these cells, the change in survivin expression was analyzed. Immunohistochemical staining was also done on CM and normal villi.
Results:
WB showed that phosphorylated STAT3 and 5, which are active forms of STAT protein, as well as survivin, were significantly up-regulated in CM. Immunohistochemistry showed positive signals of pSTATs in the cytotrophoblast and syncytiotrophoblast layer in CM but not in normal villi. In contrast, the pSTAT signal was hardly detected by WB in CC cells. However, a high level of survivin expression was maintained in CC by activation of the MEK signal pathway.
Conclusion:
An activated STAT signal may contribute to hyperplastic cell growth of trophoblasts in CM. CC cells might be obtained independently of cytokine signals for tumor cell growth during the carcinogenic process.
Insights
Signal transducer and activator of transcription (STAT) signaling and survivin are upregulated in complete mole (CM). However, choriocarcinoma (CC) cells maintain survivin expression via MEK signaling, independent of STAT activation.
Area of Science:
- Molecular biology
- Signal transduction pathways
- Trophoblastic diseases
Background:
- Previous microarray studies suggested STAT5 and survivin upregulation in complete mole (CM).
- The role of STAT-mediated signal transduction in CM and choriocarcinoma (CC) requires clarification.
Purpose of the Study:
- To investigate the status of STAT-mediated signal transduction in CM and CC.
- To determine the role of STAT and MEK signaling pathways in survivin expression in these conditions.
Main Methods:
- Western blot (WB) analysis of STAT3 and STAT5 activation in CM, normal villi, and CC cell lines.
- Inhibition of STAT and MEK pathways to assess changes in survivin expression.
- Immunohistochemical staining of CM and normal villi for pSTATs.
Main Results:
- Phosphorylated STAT3 and 5 (active forms) and survivin were significantly upregulated in CM compared to normal villi.
- Immunohistochemistry revealed pSTAT signals in CM trophoblast layers, absent in normal villi.
- CC cells showed minimal pSTAT detection by WB but maintained high survivin expression via MEK pathway activation.
Conclusions:
- Activated STAT signaling likely contributes to the hyperplastic growth of trophoblasts in CM.
- CC cells may achieve tumor growth independently of cytokine-driven STAT signals during carcinogenesis.
- MEK pathway activation is crucial for survivin expression in CC, suggesting alternative oncogenic mechanisms.
Related Concept Videos
Abnormal Proliferation
Hedgehog Signaling Pathway
TGF - β Signaling Pathway
Mitogens and the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The JAK-STAT Signaling Pathway

